Fecal microbiota transplantation for ulcerative colitis: A systematic review and meta-analysis

PLoS ONE

Volumn 11, Issue 6, 2016, Pages

  Shi, Yanqiang ^a   Dong, Yiwei ^a   Huang, Wenhui ^a   Zhu, Decong ^a   Mao, Hua ^b   Su, Peizhu ^b  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL COMPOSITION; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; COMMUNITY STRUCTURE; CORRELATIONAL STUDY; FECAL MICROBIOTA TRANSPLANTATION; HUMAN; INTESTINE FLORA; META ANALYSIS; NONHUMAN; OUTCOME ASSESSMENT; PATIENT SAFETY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; SPECIES DIVERSITY; SPECIES RICHNESS; SPECIES SIMILARITY; SYSTEMATIC REVIEW; TREATMENT OUTCOME; ULCERATIVE COLITIS; ADVERSE EFFECTS; COLITIS, ULCERATIVE; FECES; MICROBIOLOGY; PROCEDURES;

COLITIS, ULCERATIVE; FECAL MICROBIOTA TRANSPLANTATION; FECES; GASTROINTESTINAL MICROBIOME; HUMANS; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 84976400569     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0157259     Document Type: Article

References (57)

1. Danese S, Fiocchi C. Ulcerative colitis. N Engl J Med. 2011; 365(18):1713-25. doi: 10.1056/ NEJMra1102942 PMID: 22047562.
2. Stange EF, Travis SP, Vermeire S, Reinisch W, Geboes K, Barakauskiene A, et al. European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis. J Crohns Colitis. 2008; 2(1):1-23. doi: 10.1016/j.crohns.2007.11.001 PMID: 21172194.
3. Rao SS, Holdsworth CD, Read NW. Symptoms and stool patterns in patients with ulcerative colitis. Gut. 1988; 29(3):342-5. PMID: 3356365; PubMed Central PMCID: PMC1433596.
4. Berg D, Clemente JC, Colombel J-F. Can inflammatory bowel disease be permanently treated with short-term interventions on the microbiome? Expert review of gastroenterology & hepatology. 2015; 9 (6):781-95. doi: 10.1586/17474124.2015.1013031 PMID: 25665875.
5. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A. 2007; 104(34):13780-5. Epub 2007/08/19. doi: 10.1073/pnas.0706625104 PMID: 17699621; PubMed Central PMCID: PMCPmc1959459.
6. Sartor RB. Microbial Influences in Inflammatory Bowel Diseases. Gastroenterology. 2008; 134(2):577-94. doi: 10.1053/j.gastro.2007.11.059 PMID: 18242222
7. Hold GL, Smith M, Grange C, Watt ER, El-Omar EM, Mukhopadhya I. Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years? World journal of gastroenterology: WJG. 2014; 20(5):1192-210. doi: 10.3748/wjg.v20.i5.1192 PMID: 24574795.
8. Bringiotti R, Ierardi E, Lovero R, Losurdo G, Di Leo A, Principi M. Intestinal microbiota: The explosive mixture at the origin of inflammatory bowel disease? World journal of gastrointestinal pathophysiology. 2014; 5(4):550-9. Epub 2014/11/18. doi: 10.4291/wjgp.v5.i4.550 PMID: 25400998; PubMed Central PMCID: PMCPmc4231519.
9. Bartosch S, Fite A, Macfarlane GT, McMurdo ME. Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Applied and environmental microbiology. 2004; 70 (6):3575-81. Epub 2004/06/09. doi: 10.1128/aem.70.6.3575-3581.2004 PMID: 15184159; PubMed Central PMCID: PMCPmc427772.
10. Macfarlane S, Macfarlane GT. Bacterial diversity in the human gut. Advances in applied microbiology. 2004; 54:261-89. Epub 2004/07/15. doi: 10.1016/s0065-2164(04)54010-8 PMID: 15251284.
11. Cammarota G, Ianiro G, Cianci R, Bibbo S, Gasbarrini A, Curro D. The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy. Pharmacology & therapeutics. 2015; 149:191-212. Epub 2015/01/07. doi: 10.1016/j.pharmthera.2014.12.006 PMID: 25561343.
12. Negroni A, Costanzo M, Vitali R, Superti F, Bertuccini L, Tinari A, et al. Characterization of adherentinvasive Escherichia coli isolated from pediatric patients with inflammatory bowel disease. Inflammatory Bowel Diseases. 2012; 18(5):913-24. doi: 10.1002/ibd.21899 PMID: 21994005
13. Sood A, Midha V, Makharia GK, Ahuja V, Singal D, Goswami P, et al. The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis. Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association. 2009; 7(11):1202-9, 9.e1. Epub 2009/07/28. doi: 10.1016/j.cgh.2009.07.016 PMID: 19631292.
14. Tursi A, Brandimarte G, Papa A, Giglio A, Elisei W, Giorgetti GM, et al. Treatment of relapsing mild-tomoderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study. American journal of gastroenterology [Internet]. 2010; 105(10):[2218-27 pp.]. Available: http://onlinelibrary.wiley.com/o/cochrane/clcentral/ articles/222/CN-00763222/frame.html. doi: 10.1038/ajg.2010.218 PMID: 20517305
15. Oliva S, Di Nardo G, Ferrari F, Mallardo S, Rossi P, Patrizi G, et al. Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis. Alimentary Pharmacology & Therapeutics. 2012; 35(3):327-34. doi: 10.1111/j.1365-2036.2011. 04939.x BIOABS:BACD201200081102.
16. Zhang F, Luo W, Shi Y, Fan Z, Ji G. Should we standardize the 1,700-year-old fecal microbiota transplantation? The American journal of gastroenterology. 2012; 107(11):1755; author reply p.-6. Epub 2012/11/20. doi: 10.1038/ajg.2012.251 PMID: 23160295.
17. Eiseman B, Silen W, Bascom GS, Kauvar AJ. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery. 1958; 44(5):854-9. Epub 1958/11/01. PMID: 13592638.
18. Cammarota G, Masucci L, Ianiro G, Bibbo S, Dinoi G, Costamagna G, et al. Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. Aliment Pharmacol Ther. 2015; 41(9):835-43. Epub 2015/03/03. doi: 10.1111/ apt.13144 PMID: 25728808.
19. Kassam Z, Lee CH, Yuan Y, Hunt RH. Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am J Gastroenterol. 2013; 108(4):500-8. Epub 2013/03/21. doi: 10.1038/ajg.2013.59 PMID: 23511459.
20. van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013; 368(5):407-15. Epub 2013/01/18. doi: 10.1056/NEJMoa1205037 PMID: 23323867.
21. Cammarota G, Ianiro G, Gasbarrini A. Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review. J Clin Gastroenterol. 2014; 48(8):693-702. Epub 2014/01/21. doi: 10.1097/mcg.0000000000000046 PMID: 24440934.
22. Moayyedi P, Surette MG, Kim PT, Libertucci J, Wolfe M, Onischi C, et al. Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial. Gastroenterology. 2015; 149(1):102-9. doi: 10.1053/j.gastro.2015.04.001 BIOABS: BACD201500399126. PMID: 25857665
23. Rossen NG, Fuentes S, Van Der Spek MJ, Tijssen JG, Hartman JHA, Duflou A, et al. Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis. Gastroenterology. 2015; 149(1):110-8. doi: 10.1053/j.gastro.2015.03.045 PMID: 25836986
24. Colman RJ, Rubin DT. Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis. Journal of Crohn's & colitis. 2014; 8(12):1569-81. doi: 10.1016/j. crohns.2014.08.006 PMID: 25223604.
25. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and metaanalyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097. Epub 2009/07/22. doi: 10.1371/ journal.pmed.1000097 PMID: 19621072; PubMed Central PMCID: PMCPmc2707599.
26. Anderson JL, Edney RJ, Whelan K. Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 2012; 36(6):503-16. doi: 10.1111/j.1365-2036.2012.05220.x BIOABS:BACD201200414707.
27. Higgins JPT A D, Sterne JAC. (eds). Chapter 8: assessing risk of bias in included studies. In: Higgins JPT, Green S(eds). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available: www.cochrane-handbook.org. Accessed 8 Aug 2014.
28. Wells GA SB OCD, Peterson J, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available: http://www.ohri.ca/programs/clinical- epidemiology/oxford.asp Accessed 8 Aug 2014.
29. Dekkers OM, Egger M, Altman DG, Vandenbroucke JP. Distinguishing case series from cohort studies. Ann Intern Med. 2012; 156(1 Pt 1):37-40. Epub 2012/01/04. doi: 10.7326/0003-4819-156-1-201201030-00006 PMID: 22213493.
30. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled clinical trials. 1986; 7(3):177-88. Epub 1986/09/01. PMID: 3802833.
31. Wallace BC, Schmid CH, Lau J, Trikalinos TA. Meta-Analyst: software for meta-analysis of binary, continuous and diagnostic data. BMC Med Res Methodol. 2009; 9:80. Epub 2009/12/08. doi: 10.1186/ 1471-2288-9-80 PMID: 19961608; PubMed Central PMCID: PMCPmc2795760.
32. Scaldaferri F, Pecere S, Bruno G, Ianiro G, Laterza L, Gerardi V, et al. Tu1363 An Open-Label, Pilot Study to Assess Feasibility and Safety of Fecal Microbiota Transplantation in Patients With Mild-Moderate Ulcerative Colitis: Preliminary Results. Gastroenterology. 148(4):S-870. doi: 10.1016/S0016-5085 (15)32950-4
33. Borody T, Wettstein A, Campbell J, Leis S, Torres M, Finlayson S, et al. Fecal microbiota transplantation in ulcerative colitis: Review of 24 years experience. American Journal of Gastroenterology. 2012; 107:S665.
34. Angelberger S, Reinisch W, Makristathis A, Lichtenberger C, Dejaco C, Papay P, et al. Temporal Bacterial Community Dynamics Vary Among Ulcerative Colitis Patients After Fecal Microbiota Transplantation. American Journal of Gastroenterology. 2013; 108(10):1620-30. doi: 10.1038/ajg.2013.257 BIOABS:BACD201300498485. PMID: 24060759
35. Kump PK, Grochenig HP, Lackner S, Trajanoski S, Reicht G, Hoffmann KM, et al. Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis. Inflamm Bowel Dis. 2013; 19(10):2155-65. Epub 2013/08/01. doi: 10.1097/MIB. 0b013e31829ea325 PMID: 23899544.
36. Kunde S, Pham A, Bonczyk S, Crumb T, Duba M, Conrad H Jr., et al. Safety, Tolerability, and Clinical Response After Fecal Transplantation in Children and Young Adults With Ulcerative Colitis. JPGN Journal of Pediatric Gastroenterology and Nutrition. 2013; 56(6):597-601. doi: 10.1097/MPG. 0b013e318292fa0d BIOABS:BACD201300332942. PMID: 23542823
37. Landy J, Al-Hassi HO, Mann ER, Peake ST, McLaughlin SD, Ciclitira PJ, et al. A prospective controlled pilot study of fecal microbiota transplantation for chronic refractory pouchitis. Gastroenterology. 2013; 144(5):S897.
38. PK Kump HPGc, W. Spindelböck CM Hoffmann G, Gorkiewicz H. Wenzl1, W. Petritsch, G. Reicht, C. Hoegenauer. OP187 PRELIMINARY CLINICAL RESULTS OF REPEATEDLY FECAL MICROBIOTA TRANSPLANTATION (FMT) IN CHRONIC ACTIVE ULCERATIVE COLITIS. 2013.
39. Wang Mei WK-y, Ding Yan-bing, Wu Jian, Xiao Wei-ming, Li Gui-qing, Wang Ning-zhi, et al. Preliminary clinical application of treating refractory inflammation bowel disease with fecal microbiota transplantation Chinese Journal of Digestive Endoscopy. 2014.
40. Damman CJ, Brittnacher MJ, Westerhoff M, Hayden HS, Radey M, Hager KR, et al. Low Level Engraftment and Improvement following a Single Colonoscopic Administration of Fecal Microbiota to Patients with Ulcerative Colitis. PLoS One. 2015; 10(8):e0133925. Epub 2015/08/20. doi: 10.1371/journal.pone. 0133925 PMID: 26288277.
41. Kellermayer R, Nagy-Szakal D, Harris RA, Luna RA, Pitashny M, Schady D, et al. Serial Fecal Microbiota Transplantation Alters Mucosal Gene Expression in Pediatric Ulcerative Colitis. American Journal of Gastroenterology. 2015; 110(4):604-6. doi: 10.1038/ajg.2015.19 BIOABS:BACD201500302376. PMID: 25853207
42. Ren R, Sun G, Yang Y, Peng L, Zhang X, Wang S, et al. [A pilot study of treating ulcerative colitis with fecal microbiota transplantation]. Zhonghua Nei Ke Za Zhi. 2015; 54(5):411-5. Epub 2015/06/18. PMID: 26080819.
43. Suskind DL, Singh N, Nielson H, Wahbeh G. Fecal Microbial Transplant Via Nasogastric Tube for Active Pediatric Ulcerative Colitis. JPGN Journal of Pediatric Gastroenterology and Nutrition. 2015; 60 (1):27-9. doi: 10.1097/mpg.0000000000000544 BIOABS:BACD201500176484. PMID: 25162366
44. Wei Y, Zhu W, Gong J, Guo D, Gu L, Li N, et al. Fecal Microbiota Transplantation Improves the Quality of Life in Patients with Inflammatory Bowel Disease. Gastroenterology research and practice. 2015; 2015:517597-. doi: 10.1155/2015/517597 PMID: 26146498.
45. Cui B, Li P, Xu L, Zhao Y, Wang H, Peng Z, et al. Step-up fecal microbiota transplantation strategy: a pilot study for steroid-dependent ulcerative colitis. J Transl Med. 2015; 13:298. doi: 10.1186/s12967-015-0646-2 PMID: 26363929; PubMed Central PMCID: PMCPMC4567790.
46. Karolewska-Bochenek K. L-P I, Grzesiowski P., Banaszkiewicz A. A P, Gawronska A., Radzikowski A., Kotowska M. P427. Fecal microbiota transplantation in refractory pediatric UC-preliminary data. Journal of Crohn's & colitis. 2015; 9 Suppl 1:S294-S. doi: 10.1093/ecco-jcc/jju027.546
47. Bennet JD, Brinkman M. Treatment of ulcerative colitis by implantation of normal colonic flora. Lancet. 1989; 1(8630):164.
48. Borody TJ, George L, Andrews P, Brandl S, Noonan S, Cole P, et al. Bowel-flora alteration: a potential cure for inflammatory bowel disease and irritable bowel syndrome? The Medical journal of Australia. 1989; 150(10):604. Epub 1989/05/15. PMID: 2783214.
49. Borody TJ, Warren EF, Leis S, Surace R, Ashman O. Treatment of ulcerative colitis using fecal bacteriotherapy. Journal of clinical gastroenterology. 2003; 37(1):42-7. doi: 10.1097/00004836-200307000-00012 PMID: 12811208.
50. Borody T, Campbell J, Torres M, Nowak A, Leis S. Reversal of idiopathic thrombocytopenic purpura [ITP] with fecal microbiota transplantation [FMT]. American Journal of Gastroenterology. 2011; 106: S352.
51. Liu Chang-qin WW, Wu Rui-jin, Tang Mao-chun, Qiu Hua-jing, Chen Teng-fei, Yang Xue-hua, et al. A case report of fecal microbiota transplantation from healthy volunteer treating ulcerative colitis. Chinese Journal of Digestion. 2013.
52. Hohmann EL, Ananthakrishnan AN, Deshpande V. Case 25-2014: A 37-Year-Old Man with Ulcerative Colitis and Bloody Diarrhea. New England Journal of Medicine. 2014; 371(7):668-75. doi: 10.1056/ NEJMcpc1400842 BIOABS:BACD201400502132. PMID: 25119613
53. NI X-d, Li Y-s, Zhang Y-l, Tao S, Wang Z-m, LI J-s. Enteral nutrition fecal microbiota transplantation via percutaneous endoscopic cecostomy in treatment of recurrent ulcerative colitis. Parental & Enteral Nutrition. 2015; 22:29-38.
54. Vandenplas Y, Veereman G, van der Werff ten Bosch J, Goossens A, Pierard D, Samsom JN, et al. Fecal Microbial Transplantation in Early-Onset Colitis: Caution Advised. Journal of Pediatric Gastroenterology and Nutrition. 2015; 61(3):e12-e4. doi: 10.1097/mpg.0000000000000281 00005176-201509000-00023. PMID: 24399213
55. Kelly CR, Kahn S, Kashyap P, Laine L, Rubin D, Atreja A, et al. Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook. Gastroenterology. 2015; 149 (1):223-37. Epub 2015/05/20. doi: 10.1053/j.gastro.2015.05.008 PMID: 25982290.
56. Damman CJ, Miller SI, Surawicz CM, Zisman TL. The microbiome and inflammatory bowel disease: is there a therapeutic role for fecal microbiota transplantation? Am J Gastroenterol. 2012; 107(10):1452-9. Epub 2012/10/05. doi: 10.1038/ajg.2012.93 PMID: 23034604.
57. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermudez-Humaran LG, Gratadoux JJ, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A. 2008; 105(43):16731-6. doi: 10.1073/pnas. 0804812105 PMID: 18936492; PubMed Central PMCID: PMC2575488.